ACM
TECX

Atika Capital Management’s Tectonic Therapeutic TECX Stock Holding History

Atika Capital Management’s Portfolio TECX Stock Details TECX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-5,050
Closed -$942K – 119
2020
Q1 		$942K Buy
+5,050
New +$1.19M 0.18% 82

Other funds holding TECX

JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
SHI
SV Health Investors Boston, Massachusetts $32.3M AUM 20.15% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ACM
Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return

Atika Capital Management's TECX Position: Q2 2020 in Review

Atika Capital Management sold out of Tectonic Therapeutic (TECX) in Q2 2020, closing a stake of 5,050 shares — an estimated $942K sold.

Atika Capital Management first reported a position in TECX in Q1 2020 and held it in 1 quarter. The position peaked at $942K in Q1 2020. 98 funds tracked by Wall St. Rank hold TECX as of Q2 2020.

  • Atika Capital Management reported no remaining Tectonic Therapeutic position as of Q2 2020 after selling out during the quarter.
  • Atika Capital Management sold 5,050 Tectonic Therapeutic shares in Q2 2020, an estimated $942K.
  • Atika Capital Management first reported a position in Tectonic Therapeutic in Q1 2020 and held it in 1 quarter.
  • Atika Capital Management's Tectonic Therapeutic position peaked at $942K in Q1 2020.
  • 98 funds tracked by Wall St. Rank held Tectonic Therapeutic as of Q2 2020.

Based on Atika Capital Management's 13F filing for Q2 2020, filed 13 Aug 2020.